Selling And Administration Expenses Cambio Fecha
Abbott USD 2.69B 10M 2023-12
Acorda Therapeutics USD 21.82M 689K 2023-06
Agios Pharmaceuticals USD 35.3M 9.48M 2023-12
Arrowhead Research USD 26.19M 595K 2023-12
Enanta Pharmaceuticals USD 13.8M 1.18M 2023-09
Halozyme Therapeutics USD 37.61M 2.34M 2023-12
Heron Therapeutics USD 24.6M 11.84M 2023-09
Insmed USD 89.53M 1.1M 2023-12
Integra LifeSciences USD 146.52M 1.13M 2023-12
Intrexon USD 9.2M 120K 2023-09
J&J USD 5.81B 410M 2023-12
Ligand Pharmaceuticals USD 15.99M 1.34M 2023-12
Merit Medical Systems USD 95.75M 8.9M 2023-12
Peregrine Pharmaceuticals USD 6.56M 294K 2023-09
Rigel Pharmaceuticals USD 24.86M 1.45M 2023-09
Smith & Nephew USD 1.32B 1000K 2023-06
Stryker USD 1.8B 125M 2023-12
Surmodics USD 12.81M 67K 2023-09
Veracyte USD 49.06M 9.55M 2023-12
Xencor USD 15.48M 2.98M 2023-12
Zimmer Biomet Holdings USD 722.3M 50.1M 2023-12



Anika Therapeutics Gastos De Venta Y Administración - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.